Tibet Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The company employs 190 full-time employees The company went IPO on 2011-01-25. The firm sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The firm sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.
Follow-Up Questions
Quel est le ratio P/E de Tibet Pharmaceuticals Inc (TBET) ?
Le ratio P/E de Tibet Pharmaceuticals Inc est de 0
Qui est le CEO de Tibet Pharmaceuticals Inc ?
Hong Yu est le Chairman of the Board de Tibet Pharmaceuticals Inc, il a rejoint l'entreprise depuis 2010.
Quelle est la performance du prix de l'action TBET ?
Le prix actuel de TBET est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Tibet Pharmaceuticals Inc ?
Tibet Pharmaceuticals Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Tibet Pharmaceuticals Inc ?
La capitalisation boursière actuelle de Tibet Pharmaceuticals Inc est de $0
